HOLX - Hologic - Stock Price & Dividends

Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US4364401012

Diagnostic Tests, Medical Imaging Systems, Surgical Instruments

Hologic, Inc. is a leading healthcare company that specializes in developing, manufacturing, and supplying innovative medical products and solutions for women's health, diagnostics, and surgical interventions. The company's diverse portfolio is designed to facilitate early detection and treatment of various health conditions, ultimately improving patient outcomes.

The company operates through four distinct business segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. Its Diagnostics segment offers a range of molecular diagnostic assays, including Aptima, which detects infectious microorganisms, and viral load assays for Hepatitis B and C, HIV, and human cytomegalovirus. Additionally, the company provides assays for diagnosing vaginitis and detecting SARS-CoV-2.

In the Breast Health segment, Hologic offers a comprehensive suite of solutions for breast cancer care, including 3D digital mammography systems, image analytics software, and minimally invasive breast biopsy guidance systems. These products enable healthcare professionals to detect and treat breast cancer more effectively, improving patient outcomes.

The GYN Surgical segment focuses on providing innovative solutions for gynecological procedures, such as the MyoSure Hysteroscopic Tissue Removal System for removing fibroids and polyps, and the NovaSure Endometrial Ablation System for treating abnormal uterine bleeding. The company also offers the Fluent Fluid Management System for liquid distention during hysteroscopic procedures and the Acessa ProVu system for treating fibroids.

In the Skeletal Health segment, Hologic provides the Horizon DXA, a dual energy X-ray system, and the Fluoroscan Insight FD mini C-arm for performing minimally invasive orthopedic surgical procedures. These products enable healthcare professionals to diagnose and treat skeletal health conditions more accurately and effectively.

Hologic sells its products through a combination of direct sales, service forces, independent distributors, and sales representatives, ensuring that its innovative solutions reach healthcare providers and patients worldwide. With a rich history dating back to 1985, Hologic is headquartered in Marlborough, Massachusetts, and continues to drive innovation and improvement in women's health and diagnostics.

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for HOLX - Hologic  - Stock Price & Dividends

Overall Trend and Yearly Seasonality

Drawdown / Underwater Chart for HOLX - Hologic  - Stock Price & Dividends

HOLX Stock Overview

Market Cap in USD 18,863m
Sector Healthcare
Industry Medical Instruments & Supplies
GiC SubIndustry Health Care Equipment
TER 0.00%
IPO / Inception 1990-06-21

HOLX Stock Ratings

Growth 5y 55.4
Fundamental 62.8
Dividend 0.00
Rel. Performance vs Sector -0.49
Analysts 3.83/5
Fair Price Momentum 78.85 USD
Fair Price DCF 108.96 USD

HOLX Dividends

Dividend Yield 12m 0.00%
Yield on Cost 5y 0.00%
Dividends CAGR 5y 0.00%
Payout Consistency 0.0%

HOLX Growth Ratios

Growth 12m 14.89%
Growth Correlation 12m 84%
Growth Correlation 3m 36%
CAGR 5y 10.29%
CAGR/Mean DD 5y 0.88
Sharpe Ratio 12m 0.57
Alpha vs SP500 12m -13.45
Beta vs SP500 5y weekly 0.77
ValueRay RSI 38.46
Volatility GJR Garch 1y 17.48%
Price / SMA 50 -1.21%
Price / SMA 200 5.11%
Current Volume 1245.6k
Average Volume 20d 1422.6k

External Links for HOLX Stock

News
Wall Street JournalBenzingaYahoo Finance
Tweets
XStocktwits
Fund Manager Positions
DataromaStockcircle
What is the price of HOLX stocks?
As of October 05, 2024, the stock is trading at USD 80.24 with a total of 1,245,584 shares traded.
Over the past week, the price has changed by -0.72%, over one month by -1.69%, over three months by +8.29% and over the past year by +14.22%.
What are the forecast for HOLX stock price target?
According to ValueRays Forecast Model, HOLX Hologic will be worth about 86.4 in October 2025. The stock is currently trading at 80.24. This means that the stock has a potential upside of +7.65%.
Issuer Forecast Upside
Wallstreet Target Price 88.4 10.1
Analysts Target Price 86.6 7.95
ValueRay Target Price 86.4 7.65